UBS Cuts Chemours Rating to Neutral on Refrigerants Weakness
UBS reduced Chemours' price target and downgraded the stock after a sharper refrigerants reset hurt medium-term growth visibility. UBS downgraded Chemours to Neutral from Buy and lowered its price target, citing a sharper-than-anticipated decline in the company’s refrigera